|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| One year contraception with a single subdermal implant containing |
| nomegestrol acetate (Uniplant) |
| CONTRACEPTION. 1993 Jan;47(1):97-105. |
| 1 single silastic capsule containing nomegestrol acetate, Uniplant, was inserted subcutaneously in 100 Brazilian |
| women of reproductive age who desired to avoid conception. Insertions and removals of the capsules were made in |
| the gluteal region following intracutaneous local anesthesia with 2% procaine, 80 women completed 1 year of use. |
| 11 women bore the implant for 6 to 11 months. A total of 1085 women-months were recorded. 1 pregnancy occurred, |
| resulting in a Pearl Index of 1.1. Bleeding episodes similar to menstruation occurred in all women but the degree of |
| regularity varied from subject to subject. Amenorrhea developed in the range of 14 to 18% during the first 6 months of |
| use but declined to less than 10% during the last 6 months. Menorrhagia likewise was higher in the first 6 months |
| (18% in the first months) but fell to less than 10% during the last 6 months. Spotting was 5% or less. Of the 20 |
| women who did not complete 1 year of use, 9 discontinued because they found other methods were either more |
| practical or less revealing. 3 discontinued because of bleeding irregularities, 3 desired to become pregnant, 1 |
| became pregnant. Other complaints included dizziness, headache, increased blood pressure, loss of libido, painful |
| breasts and nausea. Over half of the women indicated their desire to continue using the single implant as a |
| contraceptive. (PubHealth.info Document ID: CONT2T 4558-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "One year contraception with a single subdermal implant |
| containing nomegestrol acetate (Uniplant)", is(are) Coutinho EM. The source of this article is "CONTRACEPTION. |
| 1993 Jan;47(1):97-105.". This article was published in 1993 in English language(s). (PubHealth.info® Document ID: |
| CONT2T 4558-06. All rights reserved with PubHealth.info) PIN: 9558 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |
